| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.902 | 0.003 | 0.902 | Psychostimulant | 0.785 0.004 CID_36604 0.872 0.003 CID_185859 | ||
| 0.704 | 0.004 | 0.704 | MAO inhibitor | 0.199 0.041 CID_36604 0.442 0.009 CID_185859 | ||
| 0.694 | 0.004 | 0.694 | MAO A inhibitor | 0.236 0.023 CID_36604 0.466 0.006 CID_185859 | ||
| 0.643 | 0.009 | 0.643 | Spasmolytic | 0.56 0.017 CID_36604 0.482 0.025 CID_185859 | ||
| 0.606 | 0.009 | 0.606 | Apoptosis antagonist | 0.251 0.127 CID_185859 | ||
| 0.559 | 0.004 | 0.559 | Butyrylcholinesterase inhibitor | 0.271 0.013 CID_185859 | ||
| 0.553 | 0.005 | 0.553 | Cholinergic | 0.251 0.029 CID_185859 | ||
| 0.547 | 0.005 | 0.547 | MAO B inhibitor | 0.3 0.013 CID_185859 | ||
| 0.561 | 0.019 | 0.889 | 5 Hydroxytryptamine release stimulant | 0.889 0.002 CID_36604 0.783 0.004 CID_185859 | CID_36604 | |
| 0.546 | 0.004 | 0.546 | Chelator | 0.328 0.009 CID_185859 | ||
| 0.503 | 0.004 | 0.503 | Anesthetic local | 0.251 0.02 CID_36604 0.3 0.012 CID_185859 | ||
| 0.498 | 0.02 | 0.498 | Nootropic | 0.26 0.099 CID_185859 | ||
| 0.501 | 0.033 | 0.501 | Aldehyde oxidase inhibitor | 0.4 0.047 CID_36604 0.36 0.053 CID_185859 | ||
| 0.467 | 0.005 | 0.467 | Acetylcholinesterase inhibitor | 0.217 0.028 CID_185859 | ||
| 0.449 | 0.004 | 0.449 | Acetylcholine M1 receptor antagonist | 0.206 0.04 CID_36604 0.283 0.018 CID_185859 | ||
| 0.453 | 0.011 | 0.453 | Anesthetic general | 0.298 0.034 CID_36604 0.279 0.039 CID_185859 | ||
| 0.419 | 0.007 | 0.419 | Cholinergic antagonist | 0.183 0.037 CID_36604 0.268 0.018 CID_185859 | ||
| 0.445 | 0.043 | 0.522 | GABA C receptor rho-3 antagonist | 0.387 0.067 CID_36604 0.522 0.02 CID_185859 | CID_185859 | |
| 0.398 | 0.008 | 0.398 | Acetylcholine antagonist | 0.176 0.038 CID_36604 0.262 0.018 CID_185859 | ||
| 0.401 | 0.014 | 0.563 | 5 Hydroxytryptamine uptake stimulant | 0.563 0.003 CID_36604 0.509 0.004 CID_185859 | CID_36604 | |
| 0.381 | 0.005 | 0.381 | Acetylcholine muscarinic antagonist | 0.156 0.04 CID_36604 0.27 0.012 CID_185859 | ||
| 0.363 | 0.005 | 0.363 | Alpha 2b adrenoreceptor antagonist | 0.124 0.055 CID_36604 0.199 0.024 CID_185859 | ||
| 0.388 | 0.039 | 0.451 | Vasodilator, coronary | 0.451 0.023 CID_36604 0.35 0.055 CID_185859 | CID_36604 | |
| 0.353 | 0.005 | 0.353 | Neurotrophic factor | 0.178 0.039 CID_36604 0.218 0.02 CID_185859 | ||
| 0.349 | 0.003 | 0.349 | CYP2A6 inhibitor | 0.131 0.022 CID_36604 0.181 0.01 CID_185859 | ||
| 0.338 | 0.004 | 0.338 | Acetylcholine M2 receptor antagonist | 0.054 0.051 CID_36604 0.138 0.013 CID_185859 | ||
| 0.345 | 0.04 | 0.358 | Cardiotonic | 0.358 0.037 CID_36604 0.207 0.113 CID_185859 | CID_36604 | |
| 0.296 | 0.004 | 0.296 | Acetylcholine M3 receptor antagonist | 0.073 0.03 CID_36604 0.223 0.005 CID_185859 | ||
| 0.32 | 0.041 | 0.32 | Amyloid beta aggregation inhibitor | 0.197 0.08 CID_185859 | ||
| 0.283 | 0.004 | 0.283 | Acetylcholine M4 receptor antagonist | 0.103 0.026 CID_185859 | ||
| 0.281 | 0.006 | 0.281 | Sigma receptor antagonist | 0.159 0.01 CID_36604 0.163 0.01 CID_185859 | ||
| 0.286 | 0.028 | 0.286 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.164 0.118 CID_36604 0.207 0.067 CID_185859 | ||
| 0.291 | 0.037 | 0.442 | Tyrosine 3 hydroxylase inhibitor | 0.442 0.005 CID_36604 0.346 0.017 CID_185859 | CID_36604 | |
| 0.27 | 0.062 | 0.27 | Antiamyloidogenic | 0.202 0.098 CID_36604 0.259 0.067 CID_185859 | ||
| 0.233 | 0.025 | 0.3 | 5 Hydroxytryptamine 3E antagonist | 0.3 0.005 CID_36604 0.216 0.04 CID_185859 | CID_36604 | |
| 0.211 | 0.008 | 0.219 | Folate antagonist | 0.123 0.037 CID_36604 0.219 0.007 CID_185859 | CID_185859 | |
| 0.265 | 0.062 | 0.278 | Vasodilator | 0.278 0.056 CID_36604 | CID_36604 | |
| 0.193 | 0.01 | 0.193 | Prolactin inhibitor | 0.172 0.015 CID_36604 0.16 0.018 CID_185859 | ||
| 0.225 | 0.051 | 0.225 | P-glycoprotein inhibitor | |||
| 0.205 | 0.033 | 0.205 | ATPase inhibitor | 0.175 0.065 CID_36604 0.165 0.078 CID_185859 | ||
| 0.199 | 0.03 | 0.199 | Calcium channel blocker | 0.185 0.036 CID_36604 0.116 0.092 CID_185859 | ||
| 0.275 | 0.107 | 0.319 | Antithrombotic | 0.319 0.077 CID_36604 0.276 0.107 CID_185859 | CID_36604 | |
| 0.169 | 0.005 | 0.181 | Sigma 1 receptor antagonist | 0.181 0.005 CID_36604 0.145 0.005 CID_185859 | CID_36604 | |
| 0.177 | 0.015 | 0.177 | Acetylcholine nicotinic antagonist | 0.127 0.028 CID_36604 0.105 0.036 CID_185859 | ||
| 0.191 | 0.034 | 0.228 | GABA C receptor rho-2 antagonist | 0.217 0.021 CID_36604 0.228 0.017 CID_185859 | CID_185859 | |
| 0.167 | 0.012 | 0.167 | Acetylcholine M3 receptor agonist | 0.125 0.032 CID_185859 | ||
| 0.16 | 0.007 | 0.16 | Acetylcholine M5 receptor antagonist | 0.092 0.02 CID_185859 | ||
| 0.169 | 0.018 | 0.178 | Calcium antagonist | 0.178 0.016 CID_36604 0.16 0.02 CID_185859 | CID_36604 | |
| 0.176 | 0.035 | 0.176 | Aldehyde dehydrogenase inhibitor | 0.106 0.088 CID_36604 0.13 0.062 CID_185859 | ||
| 0.159 | 0.025 | 0.185 | GABA C receptor antagonist | 0.169 0.021 CID_36604 0.185 0.016 CID_185859 | CID_185859 | |
| 0.15 | 0.021 | 0.15 | Phosphodiesterase 7B inhibitor | |||
| 0.151 | 0.022 | 0.151 | Alpha 2a adrenoreceptor antagonist | |||
| 0.211 | 0.084 | 0.219 | RNA-directed DNA polymerase inhibitor | 0.186 0.121 CID_36604 0.219 0.075 CID_185859 | CID_185859 | |
| 0.148 | 0.023 | 0.212 | Nitric-oxide synthase inhibitor | 0.204 0.009 CID_36604 0.212 0.008 CID_185859 | CID_185859 | |
| 0.134 | 0.012 | 0.134 | Adrenaline uptake inhibitor | 0.132 0.012 CID_36604 0.084 0.025 CID_185859 | ||
| 0.139 | 0.018 | 0.206 | Adrenaline agonist | 0.206 0.006 CID_36604 0.185 0.008 CID_185859 | CID_36604 | |
| 0.144 | 0.024 | 0.187 | GABA C receptor rho-1 antagonist | 0.171 0.014 CID_36604 0.187 0.01 CID_185859 | CID_185859 | |
| 0.148 | 0.028 | 0.148 | Alpha 2 adrenoreceptor antagonist | |||
| 0.233 | 0.114 | 0.364 | Insulysin inhibitor | 0.364 0.03 CID_36604 0.243 0.103 CID_185859 | CID_36604 | |
| 0.137 | 0.018 | 0.169 | Alpha adrenoreceptor agonist | 0.169 0.013 CID_36604 0.135 0.019 CID_185859 | CID_36604 | |
| 0.194 | 0.08 | 0.24 | Insulin sensitizer | 0.24 0.04 CID_36604 0.233 0.045 CID_185859 | CID_36604 | |
| 0.272 | 0.164 | 0.303 | Analgesic | 0.303 0.139 CID_36604 | CID_36604 | |
| 0.142 | 0.037 | 0.148 | Nav1.4 sodium channel blocker | 0.111 0.061 CID_36604 0.148 0.034 CID_185859 | CID_185859 | |
| 0.142 | 0.041 | 0.217 | Aminopeptidase B inhibitor | 0.217 0.018 CID_36604 0.172 0.029 CID_185859 | CID_36604 | |
| 0.157 | 0.063 | 0.211 | Thiol protease inhibitor | 0.211 0.036 CID_36604 0.206 0.037 CID_185859 | CID_36604 | |
| 0.1 | 0.007 | 0.1 | Acetylcholine M2 receptor agonist | 0.092 0.009 CID_185859 | ||
| 0.097 | 0.004 | 0.097 | Diamine oxidase inhibitor | 0.063 0.008 CID_36604 0.052 0.014 CID_185859 | ||
| 0.204 | 0.112 | 0.312 | DNA damaging | 0.312 0.053 CID_185859 | CID_185859 | |
| 0.185 | 0.094 | 0.264 | Anticonvulsant | 0.167 0.11 CID_36604 0.264 0.052 CID_185859 | CID_185859 | |
| 0.094 | 0.005 | 0.094 | Neurokinin 2 agonist | 0.04 0.03 CID_36604 0.073 0.008 CID_185859 | ||
| 0.116 | 0.029 | 0.168 | Ornithine decarboxylase inhibitor | 0.116 0.029 CID_36604 0.168 0.007 CID_185859 | CID_185859 | |
| 0.132 | 0.046 | 0.216 | Falcipain 3 inhibitor | 0.216 0.014 CID_36604 0.119 0.054 CID_185859 | CID_36604 | |
| 0.299 | 0.214 | 0.473 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.473 0.047 CID_36604 0.317 0.19 CID_185859 | CID_36604 | |
| 0.202 | 0.116 | 0.247 | Neuropeptide Y2 antagonist | 0.247 0.059 CID_36604 0.183 0.152 CID_185859 | CID_36604 | |
| 0.101 | 0.016 | 0.101 | Acyl-CoA dehydrogenase inhibitor | 0.064 0.03 CID_36604 0.087 0.02 CID_185859 | ||
| 0.104 | 0.025 | 0.11 | GABA aminotransferase inhibitor | 0.089 0.036 CID_36604 0.11 0.021 CID_185859 | CID_185859 | |
| 0.095 | 0.018 | 0.095 | Acetylcholine muscarinic agonist | 0.07 0.027 CID_185859 | ||
| 0.102 | 0.027 | 0.164 | Aminopeptidase I inhibitor | 0.164 0.01 CID_36604 0.136 0.015 CID_185859 | CID_36604 | |
| 0.102 | 0.029 | 0.129 | Glutamate decarboxylase inhibitor | 0.089 0.037 CID_36604 0.129 0.018 CID_185859 | CID_185859 | |
| 0.079 | 0.008 | 0.079 | Thymidylate synthase inhibitor | 0.074 0.009 CID_185859 | ||
| 0.097 | 0.028 | 0.116 | Estrogen-related receptor beta agonist | 0.116 0.012 CID_36604 0.085 0.052 CID_185859 | CID_36604 | |
| 0.1 | 0.034 | 0.114 | Histamine H2 receptor antagonist | 0.093 0.043 CID_36604 0.114 0.024 CID_185859 | CID_185859 | |
| 0.078 | 0.014 | 0.107 | Nicotinic alpha3beta2 receptor antagonist | 0.107 0.006 CID_36604 0.081 0.013 CID_185859 | CID_36604 | |
| 0.087 | 0.022 | 0.118 | Protease 3C (Human rhinovirus) inhibitor | 0.118 0.01 CID_36604 0.102 0.015 CID_185859 | CID_36604 | |
| 0.097 | 0.033 | 0.131 | Nicotinic alpha4beta2 receptor antagonist | 0.131 0.013 CID_36604 0.107 0.026 CID_185859 | CID_36604 | |
| 0.125 | 0.061 | 0.177 | Proteasome inhibitor | 0.17 0.036 CID_36604 0.177 0.033 CID_185859 | CID_185859 | |
| 0.123 | 0.06 | 0.182 | Calcium channel N-type blocker | 0.182 0.022 CID_36604 0.109 0.079 CID_185859 | CID_36604 | |
| 0.092 | 0.029 | 0.093 | Calcium channel L-type blocker | 0.093 0.029 CID_36604 | CID_36604 | |
| 0.216 | 0.158 | 0.372 | Vasodilator, peripheral | 0.372 0.065 CID_36604 | CID_36604 | |
| 0.177 | 0.121 | 0.185 | ErbB-1 antagonist | 0.185 0.108 CID_185859 | CID_185859 | |
| 0.117 | 0.061 | 0.155 | Calcium channel (voltage-sensitive) blocker | 0.155 0.031 CID_36604 | CID_36604 | |
| 0.184 | 0.129 | 0.28 | Calpain inhibitor | 0.28 0.041 CID_36604 0.274 0.045 CID_185859 | CID_36604 | |
| 0.126 | 0.072 | 0.352 | Alpha-N-acetylglucosaminidase inhibitor | 0.352 0.012 CID_36604 0.207 0.032 CID_185859 | CID_36604 | |
| 0.1 | 0.046 | 0.1 | Acetylcholine agonist | 0.08 0.066 CID_185859 | ||
| 0.065 | 0.012 | 0.112 | Histamine H2 receptor agonist | 0.102 0.004 CID_36604 0.112 0.003 CID_185859 | CID_185859 | |
| 0.091 | 0.042 | 0.091 | Glycine receptor antagonist | 0.091 0.041 CID_36604 0.087 0.047 CID_185859 | ||
| 0.075 | 0.026 | 0.075 | Glutamate (mGluR1) antagonist | 0.068 0.032 CID_185859 | ||
| 0.116 | 0.068 | 0.183 | Interleukin 8 antagonist | 0.183 0.018 CID_36604 0.117 0.065 CID_185859 | CID_36604 | |
| 0.067 | 0.02 | 0.067 | Acetylcholine M1 receptor agonist | |||
| 0.081 | 0.035 | 0.13 | Secretase beta inhibitor | 0.084 0.032 CID_36604 0.13 0.008 CID_185859 | CID_185859 | |
| 0.121 | 0.074 | 0.22 | Cathepsin H inhibitor | 0.22 0.018 CID_36604 0.153 0.044 CID_185859 | CID_36604 | |
| 0.091 | 0.045 | 0.23 | Inducible nitric-oxide synthase inhibitor | 0.183 0.01 CID_36604 0.23 0.006 CID_185859 | CID_185859 | |
| 0.198 | 0.153 | 0.358 | Gastrin inhibitor | 0.358 0.009 CID_36604 0.283 0.046 CID_185859 | CID_36604 | |
| 0.096 | 0.051 | 0.15 | Opioid antagonist | 0.15 0.026 CID_36604 0.077 0.074 CID_185859 | CID_36604 | |
| 0.103 | 0.059 | 0.117 | Anabolic | 0.114 0.045 CID_36604 0.117 0.042 CID_185859 | CID_185859 | |
| 0.073 | 0.029 | 0.114 | Dopamine uptake inhibitor | 0.114 0.015 CID_36604 | CID_36604 | |
| 0.062 | 0.019 | 0.062 | Squalene epoxidase inhibitor | |||
| 0.259 | 0.216 | 0.504 | 5 Hydroxytryptamine release inhibitor | 0.504 0.031 CID_36604 0.329 0.135 CID_185859 | CID_36604 | |
| 0.134 | 0.092 | 0.198 | Adenylate cyclase stimulant | 0.198 0.014 CID_36604 0.161 0.046 CID_185859 | CID_36604 | |
| 0.077 | 0.035 | 0.128 | 5 Hydroxytryptamine uptake inhibitor | 0.128 0.019 CID_36604 0.057 0.049 CID_185859 | CID_36604 | |
| 0.071 | 0.03 | 0.121 | Alpha 2 adrenoreceptor agonist | 0.121 0.01 CID_36604 0.108 0.012 CID_185859 | CID_36604 | |
| 0.081 | 0.042 | 0.094 | MAP kinase kinase 7 inhibitor | 0.084 0.037 CID_36604 0.094 0.019 CID_185859 | CID_185859 | |
| 0.103 | 0.065 | 0.103 | Toll-Like receptor 4 antagonist | 0.096 0.076 CID_185859 | ||
| 0.056 | 0.017 | 0.056 | Benzodiazepine antagonist | |||
| 0.057 | 0.019 | 0.057 | Dopamine beta hydroxylase inhibitor | 0.047 0.038 CID_36604 0.057 0.019 CID_185859 | ||
| 0.048 | 0.01 | 0.107 | Endothelial nitric-oxide synthase inhibitor | 0.075 0.005 CID_36604 0.107 0.004 CID_185859 | CID_185859 | |
| 0.096 | 0.058 | 0.096 | Antihistaminic | |||
| 0.164 | 0.126 | 0.164 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.075 | 0.038 | 0.075 | Acetylcholine M5 receptor agonist | 0.059 0.056 CID_185859 | ||
| 0.08 | 0.044 | 0.115 | Metalloproteinase-9 inhibitor | 0.084 0.041 CID_36604 0.115 0.026 CID_185859 | CID_185859 | |
| 0.066 | 0.029 | 0.086 | Beta 2 adrenoreceptor agonist | 0.086 0.006 CID_36604 0.079 0.009 CID_185859 | CID_36604 | |
| 0.112 | 0.076 | 0.112 | Alkylator | 0.101 0.087 CID_36604 0.102 0.087 CID_185859 | ||
| 0.063 | 0.03 | 0.076 | Matrix metalloproteinase 1 inhibitor | 0.069 0.026 CID_36604 0.076 0.023 CID_185859 | CID_185859 | |
| 0.07 | 0.037 | 0.112 | 5 Hydroxytryptamine 2A agonist | 0.112 0.011 CID_36604 0.08 0.027 CID_185859 | CID_36604 | |
| 0.088 | 0.056 | 0.088 | Histamine antagonist | |||
| 0.146 | 0.115 | 0.155 | Catenin beta inhibitor | 0.139 0.135 CID_36604 0.155 0.094 CID_185859 | CID_185859 | |
| 0.056 | 0.028 | 0.111 | Antimetabolite | 0.111 0.015 CID_185859 | CID_185859 | |
| 0.122 | 0.094 | 0.191 | Nav1.6 sodium channel blocker | 0.191 0.023 CID_36604 0.16 0.044 CID_185859 | CID_36604 | |
| 0.071 | 0.044 | 0.098 | Neuronal nicotinic receptor antagonist | 0.098 0.025 CID_36604 0.059 0.055 CID_185859 | CID_36604 | |
| 0.079 | 0.052 | 0.126 | Somatostatin 1 agonist | 0.126 0.021 CID_36604 0.091 0.04 CID_185859 | CID_36604 | |
| 0.054 | 0.03 | 0.073 | Lysophosphatidic acid 3 receptor antagonist | 0.072 0.013 CID_36604 0.073 0.013 CID_185859 | CID_185859 | |
| 0.057 | 0.032 | 0.12 | Immunoglobulin Fc receptor antagonist | 0.12 0.003 CID_36604 0.063 0.019 CID_185859 | CID_36604 | |
| 0.038 | 0.016 | 0.069 | Melatonin receptor 1A agonist | 0.035 0.02 CID_36604 0.069 0.005 CID_185859 | CID_185859 | |
| 0.048 | 0.026 | 0.428 | Baculoviral IAP repeat-containing protein inhibitor | 0.428 0.002 CID_36604 0.051 0.019 CID_185859 | CID_36604 | |
| 0.084 | 0.062 | 0.133 | Histamine N-methyltransferase inhibitor | 0.133 0.021 CID_36604 | CID_36604 | |
| 0.166 | 0.147 | 0.166 | Antioxidant | |||
| 0.054 | 0.036 | 0.054 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.041 | 0.023 | 0.053 | 5 Hydroxytryptamine 2B agonist | 0.053 0.011 CID_36604 0.048 0.014 CID_185859 | CID_36604 | |
| 0.056 | 0.039 | 0.086 | Alcohol oxidase inhibitor | 0.086 0.022 CID_185859 | CID_185859 | |
| 0.065 | 0.049 | 0.09 | Matrix metalloproteinase inhibitor | 0.083 0.035 CID_36604 0.09 0.031 CID_185859 | CID_185859 | |
| 0.044 | 0.029 | 0.081 | Histamine H1 receptor agonist | 0.081 0.004 CID_36604 0.062 0.008 CID_185859 | CID_36604 | |
| 0.042 | 0.027 | 0.073 | Plasmepsin II inhibitor | 0.048 0.019 CID_36604 0.073 0.007 CID_185859 | CID_185859 | |
| 0.029 | 0.015 | 0.043 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.043 0.006 CID_36604 0.029 0.016 CID_185859 | CID_36604 | |
| 0.085 | 0.072 | 0.085 | Polo-like kinase-1 inhibitor | |||
| 0.088 | 0.075 | 0.172 | Sphingomyelinase inhibitor | 0.172 0.017 CID_36604 0.089 0.074 CID_185859 | CID_36604 | |
| 0.065 | 0.052 | 0.199 | Phenylalanine 4-hydroxylase inhibitor | 0.199 0.007 CID_36604 0.086 0.033 CID_185859 | CID_36604 | |
| 0.069 | 0.056 | 0.075 | Glycine receptor agonist | 0.075 0.045 CID_185859 | CID_185859 | |
| 0.021 | 0.008 | 0.066 | Calcium-sensing receptor antagonist | 0.066 0.005 CID_185859 | CID_185859 | |
| 0.061 | 0.049 | 0.084 | Neutrophil collagenase inhibitor | 0.084 0.029 CID_36604 0.073 0.037 CID_185859 | CID_36604 | |
| 0.03 | 0.018 | 0.036 | Purinergic P2Y15 antagonist | 0.033 0.013 CID_36604 0.036 0.01 CID_185859 | CID_185859 | |
| 0.057 | 0.046 | 0.107 | Gonadotropin-releasing hormone receptor agonist | 0.107 0.008 CID_185859 | CID_185859 | |
| 0.052 | 0.041 | 0.076 | Lysine-specific demethylase 1A inhibitor | 0.076 0.014 CID_185859 | CID_185859 | |
| 0.035 | 0.024 | 0.056 | Phosphoglycerate kinase inhibitor | 0.056 0.012 CID_185859 | CID_185859 | |
| 0.038 | 0.029 | 0.038 | Substance P antagonist | |||
| 0.062 | 0.052 | 0.121 | Beta adrenoreceptor antagonist | 0.121 0.01 CID_36604 0.108 0.013 CID_185859 | CID_36604 | |
| 0.087 | 0.079 | 0.121 | Alpha 2c adrenoreceptor antagonist | 0.121 0.049 CID_185859 | CID_185859 | |
| 0.139 | 0.131 | 0.257 | Neurotensin receptor agonist | 0.257 0.02 CID_36604 0.176 0.054 CID_185859 | CID_36604 | |
| 0.048 | 0.04 | 0.048 | Antiviral (Hepatitis D) | |||
| 0.06 | 0.053 | 0.12 | Opioid mu receptor antagonist | 0.12 0.025 CID_36604 | CID_36604 | |
| 0.069 | 0.063 | 0.111 | Analgesic, opioid | 0.111 0.026 CID_36604 | CID_36604 | |
| 0.025 | 0.019 | 0.038 | Vanilloid 2 agonist | 0.038 0.004 CID_36604 | CID_36604 | |
| 0.038 | 0.035 | 0.041 | Carbonic anhydrase IV inhibitor | 0.041 0.032 CID_185859 | CID_185859 | |
| 0.069 | 0.067 | 0.091 | Metalloproteinase-2 inhibitor | 0.085 0.047 CID_36604 0.091 0.044 CID_185859 | CID_185859 | |
| 0.027 | 0.025 | 0.027 | Acetylcholine M4 receptor agonist | |||
| 0.025 | 0.024 | 0.028 | Myristoyl transferase inhibitor | 0.028 0.018 CID_36604 0.027 0.019 CID_185859 | CID_36604 | |
| 0.023 | 0.022 | 0.036 | Glutamate (mGluR1) agonist | 0.036 0.007 CID_36604 0.032 0.009 CID_185859 | CID_36604 | |
| 0.065 | 0.065 | 0.108 | Phospholipase D inhibitor | 0.108 0.011 CID_36604 0.093 0.02 CID_185859 | CID_36604 | |
| 0.083 | 0.083 | 0.143 | Protease inhibitor | 0.143 0.033 CID_36604 0.126 0.043 CID_185859 | CID_36604 | |
| 0.027 | 0.028 | 0.059 | Dipeptidyl peptidase I inhibitor | 0.059 0.007 CID_36604 0.036 0.015 CID_185859 | CID_36604 | |
| 0.072 | 0.073 | 0.087 | Opioid kappa receptor antagonist | 0.087 0.049 CID_36604 | CID_36604 | |
| 0.047 | 0.05 | 0.067 | Dipeptidyl peptidase inhibitor | 0.067 0.019 CID_36604 0.066 0.02 CID_185859 | CID_36604 | |
| 0.024 | 0.027 | 0.034 | Thrombin receptor antagonist | 0.034 0.014 CID_36604 0.031 0.016 CID_185859 | CID_36604 | |
| 0.014 | 0.018 | 0.016 | Vitamin D receptor agonist | 0.016 0.013 CID_185859 | CID_185859 | |
| 0.057 | 0.061 | 0.076 | Histone deacetylase SIRT3 inhibitor | 0.076 0.022 CID_36604 0.061 0.045 CID_185859 | CID_36604 | |
| 0.034 | 0.038 | 0.051 | Membrane dipeptidase inhibitor | 0.049 0.016 CID_36604 0.051 0.015 CID_185859 | CID_185859 | |
| 0.049 | 0.054 | 0.071 | Protein kinase C iota inhibitor | 0.071 0.031 CID_36604 0.055 0.046 CID_185859 | CID_36604 | |
| 0.05 | 0.056 | 0.08 | Sphingosine 1-phosphate receptor 3 antagonist | 0.061 0.037 CID_36604 0.08 0.017 CID_185859 | CID_185859 | |
| 0.043 | 0.049 | 0.059 | Bombesin 2 receptor antagonist | 0.058 0.025 CID_36604 0.059 0.025 CID_185859 | CID_185859 | |
| 0.021 | 0.028 | 0.028 | Urotensin II agonist | 0.028 0.017 CID_36604 | CID_36604 | |
| 0.033 | 0.041 | 0.059 | Oxytocin agonist | 0.059 0.018 CID_36604 0.043 0.029 CID_185859 | CID_36604 | |
| 0.05 | 0.057 | 0.062 | Collagenase 3 inhibitor | 0.062 0.039 CID_185859 | CID_185859 | |
| 0.038 | 0.046 | 0.042 | Dihydrofolate reductase inhibitor | 0.042 0.034 CID_185859 | CID_185859 | |
| 0.015 | 0.024 | 0.024 | Estrogen-related receptor gamma agonist | 0.024 0.006 CID_36604 | CID_36604 | |
| 0.09 | 0.098 | 0.117 | Factor V inhibitor | 0.113 0.046 CID_36604 0.117 0.042 CID_185859 | CID_185859 | |
| 0.148 | 0.157 | 0.248 | Immunostimulant | 0.22 0.109 CID_36604 0.248 0.097 CID_185859 | CID_185859 | |
| 0.039 | 0.048 | 0.051 | Dipeptidyl peptidase IV inhibitor | 0.05 0.02 CID_36604 0.051 0.02 CID_185859 | CID_185859 | |
| 0.014 | 0.023 | 0.022 | Neurokinin 1 agonist | 0.022 0.013 CID_36604 | CID_36604 | |
| 0.164 | 0.173 | 0.278 | 5 Hydroxytryptamine 1E antagonist | 0.278 0.046 CID_36604 | CID_36604 | |
| 0.015 | 0.025 | 0.024 | Alpha 2b adrenoreceptor agonist | 0.024 0.006 CID_185859 | CID_185859 | |
| 0.117 | 0.127 | 0.264 | Growth hormone agonist | 0.264 0.04 CID_36604 0.17 0.073 CID_185859 | CID_36604 | |
| 0.04 | 0.05 | 0.073 | Ribonucleoside-diphosphate reductase inhibitor | 0.073 0.028 CID_36604 0.055 0.037 CID_185859 | CID_36604 | |
| 0.047 | 0.057 | 0.107 | Opioid delta receptor antagonist | 0.107 0.029 CID_36604 | CID_36604 | |
| 0.018 | 0.028 | 0.149 | Baculoviral IAP repeat-containing protein 3 inhibitor | 0.149 0.002 CID_36604 | CID_36604 | |
| 0.05 | 0.06 | 0.072 | Cathepsin E inhibitor | 0.072 0.028 CID_36604 0.056 0.047 CID_185859 | CID_36604 | |
| 0.041 | 0.053 | 0.064 | Beta adrenoreceptor agonist | 0.064 0.007 CID_36604 0.053 0.013 CID_185859 | CID_36604 | |
| 0.008 | 0.019 | 0.166 | Baculoviral IAP repeat-containing protein 2 inhibitor | 0.166 0.002 CID_36604 | CID_36604 | |
| 0.024 | 0.036 | 0.029 | Estrogen-related receptor gamma antagonist | 0.029 0.018 CID_36604 | CID_36604 | |
| 0.046 | 0.058 | 0.056 | Angiotensin-converting enzyme inhibitor | 0.056 0.036 CID_36604 0.053 0.041 CID_185859 | CID_36604 | |
| 0.108 | 0.121 | 0.127 | Diuretic | 0.127 0.097 CID_36604 | CID_36604 | |
| 0.093 | 0.106 | 0.139 | Cell adhesion inhibitor | 0.139 0.053 CID_36604 0.111 0.073 CID_185859 | CID_36604 | |
| 0.034 | 0.048 | 0.047 | Nicotinic receptor alpha3 subunit antagonist | 0.047 0.027 CID_36604 | CID_36604 | |
| 0.038 | 0.052 | 0.075 | Ribonucleotide reductase inhibitor | 0.075 0.029 CID_36604 0.054 0.039 CID_185859 | CID_36604 | |
| 0.042 | 0.056 | 0.104 | Histamine agonist | 0.104 0.008 CID_36604 0.086 0.012 CID_185859 | CID_36604 | |
| 0.023 | 0.038 | 0.026 | Glucosylceramidase stimulant | 0.026 0.022 CID_36604 0.026 0.024 CID_185859 | CID_185859 | |
| 0.015 | 0.031 | 0.026 | Aminopeptidase P inhibitor | 0.026 0.013 CID_36604 | CID_36604 | |
| 0.047 | 0.063 | 0.096 | Bombesin 1 receptor agonist | 0.096 0.019 CID_36604 0.058 0.043 CID_185859 | CID_36604 | |
| 0.03 | 0.046 | 0.034 | Calcium-independent phospholipase A2 inhibitor | 0.034 0.025 CID_185859 | CID_185859 | |
| 0.015 | 0.036 | 0.049 | Protease (Human cytomegalovirus) inhibitor | 0.049 0.004 CID_36604 | CID_36604 | |
| 0.064 | 0.084 | 0.105 | Vanilloid 4 agonist | 0.105 0.013 CID_36604 0.073 0.057 CID_185859 | CID_36604 | |
| 0.02 | 0.041 | 0.037 | Renin inhibitor | 0.033 0.029 CID_36604 0.037 0.025 CID_185859 | CID_185859 | |
| 0.034 | 0.055 | 0.057 | Kainate receptor agonist | 0.057 0.008 CID_36604 | CID_36604 | |
| 0.043 | 0.063 | 0.064 | Matrix metalloproteinase (membrane-type) inhibitor | 0.064 0.029 CID_36604 0.055 0.038 CID_185859 | CID_36604 | |
| 0.039 | 0.061 | 0.06 | Prolyl endopeptidase inhibitor | 0.06 0.024 CID_36604 | CID_36604 | |
| 0.009 | 0.031 | 0.029 | Aminopeptidase A inhibitor | 0.029 0.006 CID_36604 | CID_36604 | |
| 0.018 | 0.041 | 0.041 | Nicotinic alpha4beta2 receptor agonist | 0.041 0.007 CID_36604 | CID_36604 | |
| 0.106 | 0.129 | 0.164 | Vanilloid 1 agonist | 0.164 0.027 CID_36604 0.115 0.101 CID_185859 | CID_36604 | |
| 0.009 | 0.032 | 0.015 | NMDA receptor phencyclidine site antagonist | 0.015 0.01 CID_36604 | CID_36604 | |
| 0.01 | 0.034 | 0.034 | Integrin alpha4beta7 antagonist | 0.034 0.008 CID_36604 | CID_36604 | |
| 0.089 | 0.113 | 0.146 | Microtubule formation inhibitor | 0.146 0.039 CID_36604 0.098 0.094 CID_185859 | CID_36604 | |
| 0.125 | 0.15 | 0.147 | Ca2+-transporting ATPase inhibitor | 0.147 0.05 CID_36604 | CID_36604 | |
| 0.031 | 0.058 | 0.096 | NMDA 2A receptor antagonist | 0.096 0.014 CID_36604 | CID_36604 | |
| 0.02 | 0.046 | 0.035 | Kainate receptor 2 antagonist | 0.035 0.026 CID_36604 | CID_36604 | |
| 0.019 | 0.046 | 0.033 | Acid ceramidase inhibitor | 0.033 0.006 CID_36604 0.028 0.013 CID_185859 | CID_36604 | |
| 0.033 | 0.06 | 0.061 | Metalloproteinase-3 inhibitor | 0.061 0.023 CID_36604 | CID_36604 | |
| 0.024 | 0.052 | 0.033 | Calpain 1 inhibitor | 0.033 0.023 CID_36604 0.031 0.028 CID_185859 | CID_36604 | |
| 0.038 | 0.066 | 0.081 | Cathepsin D inhibitor | 0.059 0.035 CID_36604 0.081 0.025 CID_185859 | CID_185859 | |
| 0.074 | 0.103 | 0.091 | Gastric antisecretory | 0.091 0.077 CID_36604 | CID_36604 | |
| 0.015 | 0.044 | 0.024 | Neuraminidase (Influenza B) inhibitor | 0.024 0.009 CID_36604 | CID_36604 | |
| 0.019 | 0.048 | 0.061 | Growth hormone releasing factor agonist | 0.061 0.009 CID_36604 | CID_36604 | |
| 0.032 | 0.062 | 0.071 | Dopamine transporter inhibitor | 0.071 0.02 CID_36604 | CID_36604 | |
| 0.017 | 0.047 | 0.031 | Lysophosphatidic acid receptor 1 agonist | 0.031 0.01 CID_36604 | CID_36604 | |
| 0.014 | 0.044 | 0.03 | Beta 1 adrenoreceptor agonist | 0.03 0.008 CID_36604 0.027 0.01 CID_185859 | CID_36604 | |
| 0.09 | 0.12 | 0.139 | Cyclooxygenase 3 inhibitor | 0.139 0.058 CID_36604 0.122 0.075 CID_185859 | CID_36604 | |
| 0.086 | 0.118 | 0.108 | TRPA1 agonist | 0.108 0.074 CID_36604 | CID_36604 | |
| 0.019 | 0.051 | 0.036 | Peptide deformylase inhibitor | 0.036 0.016 CID_36604 | CID_36604 | |
| 0.012 | 0.045 | 0.037 | Follicle-stimulating hormone agonist | 0.037 0.008 CID_185859 | CID_185859 | |
| 0.026 | 0.06 | 0.054 | Dopamine D5 agonist | 0.054 0.015 CID_36604 0.039 0.029 CID_185859 | CID_36604 | |
| 0.015 | 0.048 | 0.018 | Follicle-stimulating hormone antagonist | 0.018 0.017 CID_36604 | CID_36604 | |
| 0.03 | 0.064 | 0.059 | Geranyltranstransferase inhibitor | 0.059 0.014 CID_36604 | CID_36604 | |
| 0.052 | 0.086 | 0.128 | Beta 3 adrenoreceptor antagonist | 0.128 0.008 CID_36604 0.087 0.019 CID_185859 | CID_36604 | |
| 0.008 | 0.042 | 0.046 | Growth hormone release promoting | 0.046 0.006 CID_36604 | CID_36604 | |
| 0.036 | 0.07 | 0.057 | Collagenase inhibitor | 0.057 0.019 CID_36604 | CID_36604 | |
| 0.024 | 0.058 | 0.032 | Carboxypeptidase B inhibitor | 0.032 0.024 CID_185859 | CID_185859 | |
| 0.086 | 0.122 | 0.136 | Photosensitizer | 0.136 0.041 CID_36604 | CID_36604 | |
| 0.034 | 0.07 | 0.048 | Bombesin antagonist | 0.048 0.032 CID_36604 0.043 0.042 CID_185859 | CID_36604 | |
| 0.073 | 0.109 | 0.148 | GABA C receptor agonist | 0.148 0.034 CID_36604 0.115 0.053 CID_185859 | CID_36604 | |
| 0.025 | 0.062 | 0.039 | Erythropoietin receptor agonist | 0.039 0.03 CID_36604 | CID_36604 | |
| 0.133 | 0.171 | 0.177 | Free radical scavenger | 0.177 0.117 CID_185859 | CID_185859 | |
| 0.032 | 0.07 | 0.088 | Beta 2 adrenoreceptor antagonist | 0.088 0.009 CID_36604 0.067 0.019 CID_185859 | CID_36604 | |
| 0.038 | 0.076 | 0.047 | Cytokine production stimulant | 0.047 0.039 CID_36604 | CID_36604 | |
| 0.03 | 0.069 | 0.053 | Carbonic anhydrase VB inhibitor | 0.053 0.042 CID_185859 | CID_185859 | |
| 0.019 | 0.059 | 0.039 | Motilin receptor antagonist | 0.039 0.008 CID_36604 | CID_36604 | |
| 0.017 | 0.056 | 0.038 | Plasmepsin I inhibitor | 0.038 0.014 CID_185859 | CID_185859 | |
| 0.009 | 0.049 | 0.016 | Nicotinic alpha4 receptor agonist | 0.016 0.012 CID_36604 | CID_36604 | |
| 0.009 | 0.051 | 0.03 | Integrin alpha4 antagonist | 0.03 0.016 CID_36604 | CID_36604 | |
| 0.024 | 0.066 | 0.034 | Glutamate (mGluR3) antagonist | 0.034 0.03 CID_36604 | CID_36604 | |
| 0.04 | 0.083 | 0.061 | Epithelial sodium channel blocker | 0.061 0.028 CID_36604 0.055 0.038 CID_185859 | CID_36604 | |
| 0.018 | 0.062 | 0.039 | Calcitonin receptor agonist | 0.039 0.021 CID_36604 | CID_36604 | |
| 0.03 | 0.074 | 0.059 | Carbonic anhydrase XIV inhibitor | 0.059 0.025 CID_185859 | CID_185859 | |
| 0.135 | 0.18 | 0.345 | Interleukin agonist | 0.345 0.03 CID_36604 0.175 0.144 CID_185859 | CID_36604 | |
| 0.021 | 0.066 | 0.044 | Dipeptidyl peptidase II inhibitor | 0.044 0.012 CID_36604 | CID_36604 | |
| 0.044 | 0.089 | 0.095 | Heat shock protein 90 beta antagonist | 0.095 0.013 CID_185859 | CID_185859 | |
| 0.033 | 0.079 | 0.069 | Human rhinovirus A protease inhibitor | 0.069 0.029 CID_36604 | CID_36604 | |
| 0.052 | 0.098 | 0.149 | Glutamate dehydrogenase inhibitor | 0.149 0.016 CID_36604 | CID_36604 | |
| 0.02 | 0.068 | 0.044 | Melanocortin 1 antagonist | 0.044 0.022 CID_36604 0.033 0.032 CID_185859 | CID_36604 | |
| 0.032 | 0.079 | 0.138 | 5 Hydroxytryptamine 2 agonist | 0.138 0.005 CID_36604 0.059 0.027 CID_185859 | CID_36604 | |
| 0.025 | 0.074 | 0.032 | HCV polyprotein inhibitor | 0.032 0.029 CID_185859 | CID_185859 | |
| 0.038 | 0.087 | 0.111 | Carbonic anhydrase stimulant | 0.111 0.016 CID_36604 0.053 0.049 CID_185859 | CID_36604 | |
| 0.122 | 0.172 | 0.148 | Heat shock protein 70 antagonist | 0.148 0.05 CID_36604 | CID_36604 | |
| 0.035 | 0.085 | 0.048 | HCV NS3/NS4A protease inhibitor | 0.048 0.036 CID_36604 | CID_36604 | |
| 0.026 | 0.077 | 0.041 | Adenosine uptake inhibitor | 0.041 0.011 CID_36604 | CID_36604 | |
| 0.019 | 0.071 | 0.038 | Bombesin 1 receptor antagonist | 0.038 0.025 CID_36604 | CID_36604 | |
| 0.083 | 0.136 | 0.129 | Acetylcholine release stimulant | 0.129 0.035 CID_36604 | CID_36604 | |
| 0.016 | 0.068 | 0.024 | Thyroid hormone agonist | 0.024 0.021 CID_185859 | CID_185859 | |
| 0.02 | 0.074 | 0.026 | Hedgehog signaling activator | 0.026 0.023 CID_36604 | CID_36604 | |
| 0.014 | 0.068 | 0.034 | Gonadotropin-releasing hormone receptor antagonist | 0.034 0.024 CID_185859 | CID_185859 | |
| 0.076 | 0.13 | 0.108 | Adenylate kinase inhibitor | 0.108 0.055 CID_36604 | CID_36604 | |
| 0.03 | 0.086 | 0.046 | Cathepsin F inhibitor | 0.046 0.019 CID_36604 0.043 0.025 CID_185859 | CID_36604 | |
| 0.057 | 0.112 | 0.093 | Chymotrypsin inhibitor | 0.093 0.041 CID_36604 | CID_36604 | |
| 0.078 | 0.134 | 0.138 | DOPA decarboxylase inhibitor | 0.138 0.029 CID_36604 0.096 0.084 CID_185859 | CID_36604 | |
| 0.02 | 0.077 | 0.041 | Toll-Like receptor 2 agonist | 0.041 0.029 CID_36604 | CID_36604 | |
| 0.055 | 0.112 | 0.216 | Antiadrenergic | 0.135 0.04 CID_36604 0.216 0.021 CID_185859 | CID_185859 | |
| 0.03 | 0.088 | 0.074 | Cathepsin L inhibitor | 0.074 0.027 CID_36604 0.056 0.043 CID_185859 | CID_36604 | |
| 0.155 | 0.214 | 0.389 | Cholesterol antagonist | 0.389 0.052 CID_36604 0.263 0.116 CID_185859 | CID_36604 | |
| 0.037 | 0.096 | 0.065 | Cathepsin B inhibitor | 0.065 0.032 CID_36604 | CID_36604 | |
| 0.052 | 0.112 | 0.212 | Adrenaline antagonist | 0.127 0.041 CID_36604 0.212 0.021 CID_185859 | CID_185859 | |
| 0.068 | 0.129 | 0.128 | Interleukin 1 beta converting enzyme inhibitor | 0.128 0.029 CID_36604 | CID_36604 | |
| 0.063 | 0.123 | 0.115 | 5 Hydroxytryptamine 2 antagonist | 0.115 0.062 CID_36604 | CID_36604 | |
| 0.024 | 0.086 | 0.057 | Ornithine carbamoyltransferase inhibitor | 0.057 0.033 CID_36604 | CID_36604 | |
| 0.07 | 0.132 | 0.16 | 5 Hydroxytryptamine 2B antagonist | 0.16 0.037 CID_36604 | CID_36604 | |
| 0.01 | 0.072 | 0.043 | Arginase inhibitor | 0.043 0.02 CID_36604 | CID_36604 | |
| 0.02 | 0.082 | 0.034 | Factor XIIIa inhibitor | 0.034 0.03 CID_36604 | CID_36604 | |
| 0.065 | 0.13 | 0.178 | Ferrochelatase inhibitor | 0.178 0.028 CID_36604 | CID_36604 | |
| 0.063 | 0.128 | 0.092 | NADH dehydrogenase inhibitor | 0.092 0.054 CID_36604 | CID_36604 | |
| 0.062 | 0.127 | 0.154 | Creatine kinase inhibitor | 0.154 0.022 CID_36604 0.095 0.065 CID_185859 | CID_36604 | |
| 0.097 | 0.163 | 0.16 | Angiogenesis stimulant | 0.16 0.116 CID_36604 0.134 0.133 CID_185859 | CID_36604 | |
| 0.052 | 0.119 | 0.082 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.082 0.033 CID_36604 | CID_36604 | |
| 0.044 | 0.111 | 0.101 | Cathepsin G inhibitor | 0.101 0.033 CID_36604 | CID_36604 | |
| 0.02 | 0.088 | 0.057 | Glycine transporter 2 inhibitor | 0.057 0.026 CID_36604 | CID_36604 | |
| 0.065 | 0.133 | 0.117 | Granulocyte macrophage colony stimulating factor agonist | 0.117 0.018 CID_36604 0.088 0.056 CID_185859 | CID_36604 | |
| 0.015 | 0.084 | 0.03 | Integrin alpha2beta1 antagonist | 0.03 0.013 CID_36604 | CID_36604 | |
| 0.012 | 0.081 | 0.021 | Isoleucine-tRNA ligase inhibitor | 0.021 0.02 CID_36604 | CID_36604 | |
| 0.062 | 0.131 | 0.157 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.157 0.024 CID_36604 0.082 0.077 CID_185859 | CID_36604 | |
| 0.023 | 0.093 | 0.047 | Tryptophan 5 hydroxylase inhibitor | 0.047 0.007 CID_36604 | CID_36604 | |
| 0.008 | 0.078 | 0.025 | Histamine H4 receptor agonist | 0.025 0.008 CID_36604 | CID_36604 | |
| 0.025 | 0.095 | 0.045 | Dihydroorotase inhibitor | 0.045 0.031 CID_185859 | CID_185859 | |
| 0.054 | 0.127 | 0.071 | Cell adhesion molecule inhibitor | 0.071 0.068 CID_36604 | CID_36604 | |
| 0.02 | 0.093 | 0.042 | Ceramide glucosyltransferase inhibitor | 0.042 0.014 CID_36604 | CID_36604 | |
| 0.02 | 0.094 | 0.042 | HIV-1 protease inhibitor | 0.042 0.032 CID_36604 | CID_36604 | |
| 0.028 | 0.103 | 0.076 | Argininosuccinate synthase inhibitor | 0.076 0.027 CID_36604 | CID_36604 | |
| 0.005 | 0.08 | 0.022 | Integrin beta7 antagonist | 0.022 0.013 CID_36604 | CID_36604 | |
| 0.171 | 0.246 | 0.513 | Antiobesity | 0.513 0.034 CID_36604 0.424 0.057 CID_185859 | CID_36604 | |
| 0.025 | 0.101 | 0.046 | Neurotensin receptor antagonist | 0.046 0.031 CID_36604 | CID_36604 | |
| 0.061 | 0.138 | 0.106 | UDP-glucose 4-epimerase inhibitor | 0.106 0.055 CID_36604 | CID_36604 | |
| 0.015 | 0.093 | 0.047 | Melanocortin 4 antagonist | 0.047 0.025 CID_36604 | CID_36604 | |
| 0.022 | 0.102 | 0.058 | Opioid agonist | 0.058 0.032 CID_36604 | CID_36604 | |
| 0.005 | 0.085 | 0.026 | VLA-4 antagonist | 0.026 0.018 CID_36604 | CID_36604 | |
| 0.024 | 0.106 | 0.048 | GHS receptor agonist | 0.048 0.022 CID_36604 | CID_36604 | |
| 0.011 | 0.093 | 0.017 | Tryptophan hydroxylase 1 inhibitor | 0.017 0.012 CID_36604 | CID_36604 | |
| 0.134 | 0.216 | 0.28 | Superoxide dismutase inhibitor | 0.28 0.058 CID_36604 0.197 0.12 CID_185859 | CID_36604 | |
| 0.014 | 0.097 | 0.068 | Cathepsin L2 inhibitor | 0.068 0.014 CID_36604 | CID_36604 | |
| 0.015 | 0.099 | 0.033 | Lysophosphatidic acid 2 receptor antagonist | 0.033 0.018 CID_36604 | CID_36604 | |
| 0.063 | 0.148 | 0.089 | Bile acid receptor antagonist | 0.089 0.076 CID_36604 | CID_36604 | |
| 0.14 | 0.226 | 0.212 | DNA synthesis inhibitor | 0.212 0.105 CID_36604 | CID_36604 | |
| 0.066 | 0.154 | 0.116 | Carbonic anhydrase XV inhibitor | 0.116 0.05 CID_36604 | CID_36604 | |
| 0.02 | 0.109 | 0.055 | Opioid mu receptor agonist | 0.055 0.026 CID_36604 | CID_36604 | |
| 0.065 | 0.155 | 0.092 | CC chemokine 5 receptor agonist | 0.092 0.033 CID_36604 | CID_36604 | |
| 0.043 | 0.133 | 0.076 | Glutamate (mGluR7) antagonist | 0.076 0.032 CID_36604 | CID_36604 | |
| 0.011 | 0.103 | 0.053 | Cathepsin L1 inhibitor | 0.053 0.018 CID_36604 | CID_36604 | |
| 0.138 | 0.23 | 0.239 | Peptidyltransferase inhibitor | 0.239 0.059 CID_36604 | CID_36604 | |
| 0.016 | 0.108 | 0.046 | Melatonin 1 agonist | 0.046 0.011 CID_185859 | CID_185859 | |
| 0.038 | 0.131 | 0.072 | Kallikrein 1 inhibitor | 0.072 0.022 CID_36604 | CID_36604 | |
| 0.089 | 0.183 | 0.151 | Arachidonic acid antagonist | 0.151 0.087 CID_36604 | CID_36604 | |
| 0.015 | 0.11 | 0.035 | Somatostatin 1 antagonist | 0.035 0.03 CID_36604 | CID_36604 | |
| 0.015 | 0.109 | 0.045 | NMDA receptor subunit 3A antagonist | 0.045 0.022 CID_36604 | CID_36604 | |
| 0.045 | 0.14 | 0.074 | NMDA receptor antagonist | 0.074 0.073 CID_36604 | CID_36604 | |
| 0.21 | 0.306 | 0.537 | Caspase 9 stimulant | 0.537 0.048 CID_36604 | CID_36604 | |
| 0.019 | 0.116 | 0.04 | Integrin alpha2 antagonist | 0.04 0.02 CID_36604 | CID_36604 | |
| 0.14 | 0.239 | 0.255 | Transcription factor NF kappa B inhibitor | 0.255 0.124 CID_36604 0.212 0.158 CID_185859 | CID_36604 | |
| 0.027 | 0.126 | 0.056 | Alpha-mannosidase inhibitor | 0.056 0.033 CID_36604 | CID_36604 | |
| 0.059 | 0.159 | 0.123 | Carbonic anhydrase III inhibitor | 0.123 0.042 CID_36604 | CID_36604 | |
| 0.019 | 0.119 | 0.05 | Melanocortin antagonist | 0.05 0.03 CID_36604 | CID_36604 | |
| 0.018 | 0.119 | 0.038 | Growth hormone release inhibitor | 0.038 0.033 CID_36604 | CID_36604 | |
| 0.025 | 0.127 | 0.099 | Beta 1 adrenoreceptor antagonist | 0.099 0.01 CID_36604 0.075 0.022 CID_185859 | CID_36604 | |
| 0.031 | 0.133 | 0.091 | Sphingosine kinase 2 inhibitor | 0.091 0.01 CID_36604 | CID_36604 | |
| 0.141 | 0.245 | 0.236 | Nitric-oxide synthase stimulant | 0.236 0.043 CID_36604 0.189 0.108 CID_185859 | CID_36604 | |
| 0.02 | 0.127 | 0.043 | AMPA 4 receptor antagonist | 0.043 0.022 CID_36604 | CID_36604 | |
| 0.016 | 0.124 | 0.052 | Histone deacetylase 7 inhibitor | 0.052 0.018 CID_36604 | CID_36604 | |
| 0.031 | 0.14 | 0.067 | Bombesin 3 receptor antagonist | 0.067 0.026 CID_36604 | CID_36604 | |
| 0.026 | 0.135 | 0.062 | Carbamoyl phosphate synthetase inhibitor | 0.062 0.041 CID_36604 | CID_36604 | |
| 0.034 | 0.146 | 0.063 | Purinergic P2X1 antagonist | 0.063 0.04 CID_36604 | CID_36604 | |
| 0.037 | 0.149 | 0.067 | Corticotropin releasing factor 2 receptor antagonist | 0.067 0.033 CID_36604 | CID_36604 | |
| 0.021 | 0.137 | 0.037 | Glutamate (mGluR8) agonist | 0.037 0.029 CID_36604 | CID_36604 | |
| 0.06 | 0.177 | 0.125 | Mucolytic | 0.125 0.05 CID_36604 | CID_36604 | |
| 0.064 | 0.181 | 0.115 | Glutamate release inhibitor | 0.115 0.025 CID_36604 | CID_36604 | |
| 0.036 | 0.154 | 0.075 | 5 Hydroxytryptamine 5A antagonist | 0.075 0.027 CID_36604 | CID_36604 | |
| 0.078 | 0.2 | 0.144 | Transcription factor STAT6 inhibitor | 0.144 0.028 CID_36604 | CID_36604 | |
| 0.024 | 0.146 | 0.069 | Aminopeptidase microsomal inhibitor | 0.069 0.032 CID_36604 | CID_36604 | |
| 0.024 | 0.146 | 0.041 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.041 0.03 CID_36604 | CID_36604 | |
| 0.02 | 0.143 | 0.062 | Sphingosine kinase 1 inhibitor | 0.062 0.008 CID_36604 | CID_36604 | |
| 0.017 | 0.142 | 0.042 | Mannosidase inhibitor | 0.042 0.036 CID_36604 | CID_36604 | |
| 0.107 | 0.231 | 0.164 | Phospholipase C inhibitor | 0.164 0.081 CID_36604 | CID_36604 | |
| 0.016 | 0.142 | 0.05 | Aminopeptidase N inhibitor | 0.05 0.031 CID_36604 | CID_36604 | |
| 0.009 | 0.135 | 0.024 | Motilin receptor agonist | 0.024 0.014 CID_36604 | CID_36604 | |
| 0.021 | 0.147 | 0.049 | Potassium channel Kv1.1 blocker | 0.049 0.014 CID_36604 | CID_36604 | |
| 0.028 | 0.156 | 0.124 | Catalase inhibitor | 0.124 0.032 CID_36604 | CID_36604 | |
| 0.023 | 0.152 | 0.045 | CC chemokine 4 receptor antagonist | 0.045 0.036 CID_36604 | CID_36604 | |
| 0.024 | 0.154 | 0.047 | VCAM-1 antagonist | 0.047 0.012 CID_36604 | CID_36604 | |
| 0.024 | 0.154 | 0.047 | VCAM antagonist | 0.047 0.012 CID_36604 | CID_36604 | |
| 0.008 | 0.138 | 0.028 | AMPA 3 receptor antagonist | 0.028 0.022 CID_36604 | CID_36604 | |
| 0.03 | 0.164 | 0.058 | 5 Hydroxytryptamine 7 agonist | 0.058 0.034 CID_36604 | CID_36604 | |
| 0.043 | 0.176 | 0.07 | Glutamate (mGluR6) antagonist | 0.07 0.039 CID_36604 | CID_36604 | |
| 0.017 | 0.152 | 0.035 | Glutamate (mGluR3) agonist | 0.035 0.016 CID_36604 | CID_36604 | |
| 0.023 | 0.157 | 0.061 | Phosphofructokinase-1 inhibitor | 0.061 0.056 CID_36604 | CID_36604 | |
| 0.053 | 0.191 | 0.115 | Lanosterol 14 alpha demethylase inhibitor | 0.115 0.035 CID_36604 | CID_36604 | |
| 0.036 | 0.175 | 0.059 | Interferon inducer | 0.059 0.057 CID_36604 | CID_36604 | |
| 0.039 | 0.179 | 0.071 | Interferon agonist | 0.071 0.068 CID_36604 | CID_36604 | |
| 0.019 | 0.159 | 0.041 | Histone deacetylase 9 inhibitor | 0.041 0.024 CID_36604 | CID_36604 | |
| 0.031 | 0.171 | 0.067 | 5 Hydroxytryptamine 5 antagonist | 0.067 0.028 CID_36604 | CID_36604 | |
| 0.064 | 0.206 | 0.114 | Toll-Like receptor 2 antagonist | 0.114 0.084 CID_36604 | CID_36604 | |
| 0.049 | 0.192 | 0.087 | Triose-phosphate isomerase inhibitor | 0.087 0.064 CID_36604 | CID_36604 | |
| 0.028 | 0.174 | 0.089 | Sphingosine kinase inhibitor | 0.089 0.011 CID_36604 | CID_36604 | |
| 0.027 | 0.174 | 0.091 | Histidine decarboxylase inhibitor | 0.091 0.036 CID_36604 | CID_36604 | |
| 0.032 | 0.18 | 0.123 | 5 Hydroxytryptamine 2C antagonist | 0.123 0.035 CID_36604 | CID_36604 | |
| 0.012 | 0.162 | 0.036 | Melatonin agonist | 0.036 0.019 CID_185859 | CID_185859 | |
| 0.021 | 0.175 | 0.233 | 5 Hydroxytryptamine 1F antagonist | 0.233 0.008 CID_36604 | CID_36604 | |
| 0.13 | 0.285 | 0.238 | Immunosuppressant | 0.238 0.158 CID_36604 | CID_36604 | |
| 0.02 | 0.176 | 0.046 | Adenylate cyclase 1 inhibitor | 0.046 0.032 CID_36604 | CID_36604 | |
| 0.172 | 0.33 | 0.503 | Calcium channel L-type activator | 0.503 0.026 CID_36604 | CID_36604 | |
| 0.095 | 0.253 | 0.228 | Neurotrophic factor enhancer | 0.228 0.053 CID_36604 | CID_36604 | |
| 0.019 | 0.18 | 0.04 | AICAR transformylase inhibitor | 0.04 0.038 CID_36604 | CID_36604 | |
| 0.029 | 0.19 | 0.108 | NMDA receptor agonist | 0.108 0.016 CID_36604 | CID_36604 | |
| 0.004 | 0.167 | 0.02 | Nicotinic acid receptor 1 antagonist | 0.02 0.008 CID_36604 | CID_36604 | |
| 0.011 | 0.177 | 0.026 | ICAM 1 antagonist | 0.026 0.01 CID_36604 | CID_36604 | |
| 0.011 | 0.178 | 0.043 | Cannabinoid CB2 receptor antagonist | 0.043 0.041 CID_185859 | CID_185859 | |
| 0.143 | 0.317 | 0.255 | Interleukin 2 agonist | 0.255 0.113 CID_36604 | CID_36604 | |
| 0.06 | 0.234 | 0.228 | Nav1.2 sodium channel blocker | 0.228 0.026 CID_36604 | CID_36604 | |
| 0.025 | 0.2 | 0.054 | Botulinum neurotoxin type A inhibitor | 0.054 0.048 CID_36604 | CID_36604 | |
| 0.057 | 0.235 | 0.126 | Glutamate (mGluR7) agonist | 0.126 0.024 CID_36604 | CID_36604 | |
| 0.043 | 0.222 | 0.101 | Cystathionine beta-synthase inhibitor | 0.101 0.076 CID_36604 | CID_36604 | |
| 0.049 | 0.228 | 0.177 | Adenylate cyclase inhibitor | 0.177 0.031 CID_36604 | CID_36604 | |
| 0.019 | 0.198 | 0.056 | Glucagon-like peptide 1 agonist | 0.056 0.051 CID_36604 | CID_36604 | |
| 0.038 | 0.22 | 0.102 | Expectorant | 0.102 0.066 CID_36604 | CID_36604 | |
| 0.017 | 0.199 | 0.062 | 5 Hydroxytryptamine 1D antagonist | 0.062 0.046 CID_36604 | CID_36604 | |
| 0.061 | 0.244 | 0.16 | Peroxidase inhibitor | 0.16 0.073 CID_36604 | CID_36604 | |
| 0.015 | 0.2 | 0.031 | GHS receptor antagonist | 0.031 0.024 CID_36604 | CID_36604 | |
| 0.014 | 0.201 | 0.064 | 5 Hydroxytryptamine agonist | 0.064 0.051 CID_36604 | CID_36604 | |
| 0.048 | 0.239 | 0.103 | Caspase 3 inhibitor | 0.103 0.087 CID_36604 | CID_36604 | |
| 0.022 | 0.214 | 0.041 | Glutamate (mGluR4) antagonist | 0.041 0.036 CID_36604 | CID_36604 | |
| 0.034 | 0.228 | 0.114 | Caspase 9 inhibitor | 0.114 0.01 CID_36604 | CID_36604 | |
| 0.087 | 0.281 | 0.161 | Succinate dehydrogenase inhibitor | 0.161 0.094 CID_36604 | CID_36604 | |
| 0.014 | 0.208 | 0.052 | NMDA receptor subunit 3B antagonist | 0.052 0.023 CID_36604 | CID_36604 | |
| 0.017 | 0.211 | 0.086 | 5 Hydroxytryptamine 1B antagonist | 0.086 0.031 CID_36604 | CID_36604 | |
| 0.074 | 0.268 | 0.142 | Sphingosine 1-phosphate receptor 2 antagonist | 0.142 0.053 CID_36604 | CID_36604 | |
| 0.021 | 0.217 | 0.085 | Sphingosine 1-phosphate receptor 4 agonist | 0.085 0.033 CID_36604 | CID_36604 | |
| 0.016 | 0.213 | 0.031 | Vanilloid 4 antagonist | 0.031 0.027 CID_36604 | CID_36604 | |
| 0.006 | 0.205 | 0.035 | Sirtuin 2 inhibitor | 0.035 0.021 CID_36604 | CID_36604 | |
| 0.153 | 0.353 | 0.225 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.225 0.106 CID_36604 | CID_36604 | |
| 0.076 | 0.28 | 0.135 | Melanin inhibitor | 0.135 0.105 CID_36604 | CID_36604 | |
| 0.122 | 0.327 | 0.293 | Sodium/bile acid cotransporter inhibitor | 0.231 0.149 CID_36604 0.293 0.085 CID_185859 | CID_185859 | |
| 0.053 | 0.266 | 0.086 | 3C-Like protease (SARS coronavirus) inhibitor | 0.086 0.054 CID_36604 | CID_36604 | |
| 0.066 | 0.28 | 0.154 | Neuropeptide Y1 antagonist | 0.154 0.058 CID_36604 | CID_36604 | |
| 0.025 | 0.239 | 0.076 | Potassium channel (ATP-sensitive) blocker | 0.076 0.033 CID_36604 | CID_36604 | |
| 0.03 | 0.246 | 0.076 | Potassium channel (Tandem pore domain) blocker | 0.076 0.045 CID_36604 | CID_36604 | |
| 0.04 | 0.258 | 0.097 | Protein kinase C gamma inhibitor | 0.097 0.083 CID_36604 | CID_36604 | |
| 0.082 | 0.304 | 0.14 | Sphingosine 1-phosphate receptor 5 antagonist | 0.14 0.08 CID_36604 | CID_36604 | |
| 0.078 | 0.299 | 0.146 | Interferon gamma antagonist | 0.146 0.083 CID_36604 | CID_36604 | |
| 0.095 | 0.317 | 0.359 | Calpain 2 inhibitor | 0.359 0.082 CID_36604 | CID_36604 | |
| 0.024 | 0.25 | 0.083 | Thrombin inhibitor | 0.083 0.038 CID_36604 0.071 0.054 CID_185859 | CID_36604 | |
| 0.025 | 0.251 | 0.072 | Acetylcholine nicotinic agonist | 0.072 0.068 CID_36604 | CID_36604 | |
| 0.135 | 0.364 | 0.232 | Ca(v)3.3 blocker | 0.232 0.13 CID_36604 | CID_36604 | |
| 0.041 | 0.278 | 0.192 | Nav1.3 sodium channel blocker | 0.192 0.027 CID_36604 | CID_36604 | |
| 0.03 | 0.269 | 0.093 | Potassium channel activator | 0.093 0.056 CID_36604 | CID_36604 | |
| 0.118 | 0.363 | 0.378 | Histamine release inhibitor | 0.378 0.087 CID_36604 | CID_36604 | |
| 0.027 | 0.282 | 0.147 | Ca(v)2.2 blocker | 0.147 0.03 CID_36604 | CID_36604 | |
| 0.079 | 0.34 | 0.212 | Cyclic AMP phosphodiesterase inhibitor | 0.212 0.085 CID_36604 | CID_36604 | |
| 0.044 | 0.307 | 0.154 | Transcription factor NF kappa B stimulant | 0.154 0.015 CID_36604 | CID_36604 | |
| 0.054 | 0.324 | 0.117 | Aurora-C kinase inhibitor | 0.117 0.114 CID_36604 | CID_36604 | |
| 0.051 | 0.323 | 0.132 | Histone deacetylase SIRT1 inhibitor | 0.132 0.078 CID_36604 | CID_36604 | |
| 0.026 | 0.32 | 0.091 | Urease inhibitor | 0.091 0.078 CID_36604 | CID_36604 | |
| 0.017 | 0.312 | 0.05 | Potassium channel (ATP-sensitive) activator | 0.05 0.03 CID_36604 | CID_36604 | |
| 0.018 | 0.316 | 0.052 | Potassium channel (Inward rectifier) activator | 0.052 0.031 CID_36604 | CID_36604 | |
| 0.045 | 0.344 | 0.143 | Cell wall synthesis inhibitor | 0.143 0.072 CID_36604 | CID_36604 | |
| 0.074 | 0.373 | 0.144 | Papain-like protease (SARS coronavirus) inhibitor | 0.144 0.04 CID_36604 | CID_36604 | |
| 0.065 | 0.368 | 0.131 | CF transmembrane conductance regulator agonist | 0.131 0.115 CID_36604 | CID_36604 | |
| 0.033 | 0.337 | 0.136 | Thrombolytic | 0.136 0.093 CID_185859 | CID_185859 | |
| 0.052 | 0.357 | 0.115 | Sphingosine 1-phosphate receptor 4 antagonist | 0.115 0.082 CID_36604 | CID_36604 | |
| 0.061 | 0.371 | 0.172 | 3C-like protease (Human coronavirus) inhibitor | 0.172 0.072 CID_36604 | CID_36604 | |
| 0.012 | 0.326 | 0.051 | Potassium channel (Inward rectifier) blocker | 0.051 0.033 CID_36604 | CID_36604 | |
| 0.034 | 0.348 | 0.085 | Falcipain inhibitor | 0.085 0.068 CID_36604 | CID_36604 | |
| 0.033 | 0.354 | 0.081 | Falcipain 2 inhibitor | 0.081 0.068 CID_36604 | CID_36604 | |
| 0.073 | 0.397 | 0.256 | Transcription factor STAT3 inhibitor | 0.256 0.079 CID_36604 | CID_36604 | |
| 0.113 | 0.438 | 0.69 | Apoptosis agonist | 0.69 0.032 CID_36604 | CID_36604 | |
| 0.053 | 0.385 | 0.168 | Antipruritic | 0.168 0.075 CID_36604 | CID_36604 | |
| 0.097 | 0.437 | 0.308 | Calcium channel activator | 0.308 0.084 CID_36604 | CID_36604 | |
| 0.025 | 0.383 | 0.065 | Trypsin inhibitor | 0.065 0.039 CID_36604 | CID_36604 | |
| 0.078 | 0.454 | 0.246 | Antibacterial | 0.246 0.181 CID_36604 | CID_36604 | |
| 0.057 | 0.437 | 0.162 | Focal adhesion kinase 2 inhibitor | 0.162 0.111 CID_36604 | CID_36604 | |
| 0.036 | 0.418 | 0.218 | Nav1.1 sodium channel blocker | 0.218 0.016 CID_36604 | CID_36604 | |
| 0.009 | 0.415 | 0.039 | Acetyl-CoA carboxylase inhibitor | 0.039 0.032 CID_36604 | CID_36604 | |
| 0.055 | 0.479 | 0.255 | Transcription factor STAT inhibitor | 0.255 0.083 CID_36604 | CID_36604 | |
| 0.02 | 0.446 | 0.134 | Aminoacyl-tRNA synthetase inhibitor | 0.134 0.024 CID_36604 0.091 0.057 CID_185859 | CID_36604 | |
| 0.009 | 0.44 | 0.061 | Plasminogen activator inhibitor | 0.061 0.039 CID_36604 | CID_36604 | |
| 0.026 | 0.46 | 0.096 | Nav1.5 sodium channel blocker | 0.096 0.092 CID_36604 | CID_36604 | |
| 0.018 | 0.452 | 0.277 | Bronchodilator | 0.277 0.01 CID_36604 0.186 0.021 CID_185859 | CID_36604 | |
| 0.045 | 0.485 | 0.131 | Tumour necrosis factor antagonist | 0.131 0.125 CID_36604 | CID_36604 | |
| 0.034 | 0.507 | 0.093 | Toll-Like receptor 3 antagonist | 0.093 0.062 CID_36604 | CID_36604 | |
| 0.004 | 0.538 | 0.095 | Beta tubulin antagonist | 0.095 0.024 CID_36604 | CID_36604 | |
| 0.02 | 0.587 | 0.145 | Interleukin antagonist | 0.145 0.122 CID_36604 | CID_36604 | |
| 0.018 | 0.642 | 0.053 | Alpha 1b adrenoreceptor agonist | 0.053 0.03 CID_36604 | CID_36604 | |
| 0.01 | 0.825 | 0.137 | Interleukin 6 antagonist | 0.137 0.11 CID_36604 | CID_36604 | |
| 0.023 | 0.88 | 0.373 | Caspase 3 stimulant | 0.373 0.052 CID_36604 | CID_36604 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |